Access Statistics for Toshiaki Iizuka

Author contact details at EconPapers.

Working Paper File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
Are Quality-Adjusted Medical Prices Declining for Chronic Disease? Evidence from Diabetes Care in Four Health Systems 0 0 0 55 1 2 17 65
Asymmetric Demand Response when Prices Increase and Decrease: The Case of Child Healthcare 0 0 0 17 0 3 14 60
Asymmetric Demand Response when Prices Increase and Decrease: The Case of Child Healthcare 0 0 0 10 1 1 13 54
Cognitive versus Physical Impairment and the Use and Cost of Long-Term Care in Japan 0 5 5 5 1 7 7 7
Drug Advertising and Health Habit 0 0 0 70 0 2 10 425
False Alarm? Estimating the Marginal Value of Health Signals 0 0 0 49 0 0 16 75
Free for Children? Patient Cost-sharing and Healthcare Utilization 0 0 0 27 1 1 15 71
Free for Children? Patient Cost-sharing and Healthcare Utilization 0 0 0 18 3 4 29 136
Is Zero a Special Price? Evidence from Child Healthcare 0 0 3 36 2 3 22 119
Long-term Care in Japan 0 1 4 24 0 8 45 77
Promoting Innovation in Small Markets: Evidence from the market for rare and intractable diseases 0 0 0 24 0 0 7 46
Robots and Labor in Nursing Homes 0 0 1 39 2 4 26 52
Robots and Labor in the Service Sector: Evidence from Nursing Homes 0 0 0 60 3 5 17 143
Total Working Papers 0 6 13 434 14 40 238 1,330


Journal Article File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
An Empirical Analysis of Planned Obsolescence 0 0 1 75 0 1 22 271
Are quality-adjusted medical prices declining for chronic disease? Evidence from diabetes care in four health systems 0 0 0 1 0 0 18 43
Asymmetric Demand Response When Prices Increase and Decrease: The Case of Child Health Care 0 0 2 8 1 3 21 114
Cartel sustainability in retail markets: Evidence from a health service sector 0 0 0 19 0 1 16 134
Comment on “How does the Price Regulation Policy Impact on Patient–Nurse Ratios and the Length of Hospital Stays in Japanese Hospitals?” 0 0 0 1 0 0 11 31
Comment on “Sustainable Health Financing for COVID‐19 Preparedness and Response in Asia and the Pacific” 0 0 0 5 0 2 7 15
DIRECT TO CONSUMER ADVERTISING AND PRESCRIPTION CHOICE 0 0 1 79 0 0 5 240
DURABLE GOODS PRICE CYCLES: THEORY AND EVIDENCE FROM THE TEXTBOOK MARKET 0 0 0 9 0 0 9 75
Does Higher Malpractice Pressure Deter Medical Errors? 0 0 0 36 0 0 7 148
Effect of age-based left-digit bias on stroke diagnosis: Regression discontinuity design 0 1 2 3 0 3 17 23
Experts' agency problems: evidence from the prescription drug market in Japan 0 0 0 34 1 2 18 150
False alarm? Estimating the marginal value of health signals 0 0 0 6 1 3 29 90
GENERIC ENTRY IN A REGULATED PHARMACEUTICAL MARKET* 0 0 0 34 1 2 7 126
Is Zero a Special Price? Evidence from Child Health Care 0 1 2 14 0 3 22 65
Patient cost sharing and medical expenditures for the Elderly 0 0 4 27 0 2 19 140
Physician Agency and Adoption of Generic Pharmaceuticals 0 2 6 67 0 3 17 299
Promoting innovation in small markets: Evidence from the market for rare and intractable diseases 0 0 0 3 0 0 9 40
Robots and labor in nursing homes 0 0 2 2 2 6 54 78
The Effect of Prescription Drug Advertising on Doctor Visits 0 0 3 83 0 0 19 341
The Impact of Physician Supply on the Healthcare System: Evidence from Japan's New Residency Program 0 0 0 12 0 0 21 60
The generic drug market in Japan: will it finally take off? 0 0 1 33 0 0 15 109
What Explains the Use of Direct‐to‐Consumer Advertising of Prescription Drugs? 0 0 0 119 1 3 12 442
Total Journal Articles 0 4 24 670 7 34 375 3,034


Chapter File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
Long-Term Care in Japan 0 0 0 0 0 3 3 3
Total Chapters 0 0 0 0 0 3 3 3


Statistics updated 2026-10-11